Please login to the form below

Not currently logged in
Email:
Password:

NHS seeks 'solution creators' from within pharma

Health service is moving to a 'new era' of industry relations, says NHS England

IQVIA UK marketing access

The NHS is moving into a new era of relations with the pharmaceutical industry, according to NHS England.

But to make the most of this it needs ‘solution creators’ to come forward, commercial director of specialised commissioning Peter Huskinson (pictured, seated, centre) told a London meeting earlier this week.

Addressing IQVIA’s UK Market Access Summit he said: “Not withstanding the cold trade winds of Brexit, which I totally understand, I would content that we are moving into a new era in how we work and in what’s going on in pharma.

“Some of that you can see in national planning documents, and the contextual stuff that’s happening in the NHS, but also you can see it in what’s happening to medicine itself, with the technology.”

There has also been “a degree of convergence” among the people and bodies that work on assessing new medicines, he added, whether they be involved with NICE, the Cancer Drugs Fund or patient access schemes.

However, he was clear about what NHS England wanted from the pharmaceutical industry.

“Ultimately, we really are about working with ‘solution creators’ and not lobbyists. So if you, or anyone in your organisation thinks, that making a bigger stink about something will get you preferential treatment, I’ve got to tell you that my real equity goal is health benefits [for] every patient equally.

“The job of the healthcare system is to listen to the quietest voices, because they’re the people that often get left behind in care.”

However, a warning note about partnership working was sounded by another of the Summit’s speakers, Andrew White (picuted, seated, second from the right), who is medicines optimisation lead within the Greater Manchester Health and Social Care Partnership.

He said: “There’s a lot of people who have got a lot of bad history [and] there are a number of people with ‘scars on the back’.”

But he added: “That’s not to say that we can’t do great things.”

Article by
Dominic Tyer

16th March 2018

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...

Infographics